Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling one batch of its non-interchangeable Semglee (insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens due to the potential for a missing label, the U.S. Food and Drug Administration said.
from RTT - Top Story https://ift.tt/3qJX3HB
via IFTTT
from RTT - Top Story https://ift.tt/3qJX3HB
via IFTTT
Comments
Post a Comment